ID   MINP1_CHICK             Reviewed;         448 AA.
AC   F1NPQ2; Q92170;
DT   07-SEP-2016, integrated into UniProtKB/Swiss-Prot.
DT   07-SEP-2016, sequence version 3.
DT   02-DEC-2020, entry version 49.
DE   RecName: Full=Multiple inositol polyphosphate phosphatase 1 {ECO:0000250|UniProtKB:Q9UNW1};
DE            EC=3.1.3.62 {ECO:0000269|PubMed:16759730};
DE   AltName: Full=2,3-bisphosphoglycerate 3-phosphatase {ECO:0000250|UniProtKB:Q9UNW1};
DE            Short=2,3-BPG phosphatase {ECO:0000250|UniProtKB:Q9UNW1};
DE            EC=3.1.3.80 {ECO:0000250|UniProtKB:Q9UNW1};
DE   AltName: Full=Band 17 {ECO:0000303|PubMed:8660956};
DE   AltName: Full=Histidine phosphatase of the endoplasmic reticulum 1 {ECO:0000303|PubMed:9472008};
DE            Short=HiPER1 {ECO:0000303|PubMed:9472008};
DE   Flags: Precursor;
GN   Name=MINPP1;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC   Phasianinae; Gallus.
OX   NCBI_TaxID=9031 {ECO:0000312|Proteomes:UP000000539};
RN   [1] {ECO:0000312|EMBL:AAB97100.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=8660956; DOI=10.1006/excr.1996.0219;
RA   Reynolds S.D., Johnston C., Leboy P.S., O'Keefe R.J., Puzas J.E.,
RA   Rosier R.N., Reynolds P.R.;
RT   "Identification and characterization of a unique chondrocyte gene involved
RT   in transition to hypertrophy.";
RL   Exp. Cell Res. 226:197-207(1996).
RN   [2] {ECO:0000312|Proteomes:UP000000539}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Red jungle fowl {ECO:0000312|Proteomes:UP000000539};
RX   PubMed=15592404; DOI=10.1038/nature03154;
RA   Hillier L.W., Miller W., Birney E., Warren W., Hardison R.C., Ponting C.P.,
RA   Bork P., Burt D.W., Groenen M.A.M., Delany M.E., Dodgson J.B.,
RA   Chinwalla A.T., Cliften P.F., Clifton S.W., Delehaunty K.D., Fronick C.,
RA   Fulton R.S., Graves T.A., Kremitzki C., Layman D., Magrini V.,
RA   McPherson J.D., Miner T.L., Minx P., Nash W.E., Nhan M.N., Nelson J.O.,
RA   Oddy L.G., Pohl C.S., Randall-Maher J., Smith S.M., Wallis J.W.,
RA   Yang S.-P., Romanov M.N., Rondelli C.M., Paton B., Smith J., Morrice D.,
RA   Daniels L., Tempest H.G., Robertson L., Masabanda J.S., Griffin D.K.,
RA   Vignal A., Fillon V., Jacobbson L., Kerje S., Andersson L.,
RA   Crooijmans R.P., Aerts J., van der Poel J.J., Ellegren H., Caldwell R.B.,
RA   Hubbard S.J., Grafham D.V., Kierzek A.M., McLaren S.R., Overton I.M.,
RA   Arakawa H., Beattie K.J., Bezzubov Y., Boardman P.E., Bonfield J.K.,
RA   Croning M.D.R., Davies R.M., Francis M.D., Humphray S.J., Scott C.E.,
RA   Taylor R.G., Tickle C., Brown W.R.A., Rogers J., Buerstedde J.-M.,
RA   Wilson S.A., Stubbs L., Ovcharenko I., Gordon L., Lucas S., Miller M.M.,
RA   Inoko H., Shiina T., Kaufman J., Salomonsen J., Skjoedt K., Wong G.K.-S.,
RA   Wang J., Liu B., Wang J., Yu J., Yang H., Nefedov M., Koriabine M.,
RA   Dejong P.J., Goodstadt L., Webber C., Dickens N.J., Letunic I., Suyama M.,
RA   Torrents D., von Mering C., Zdobnov E.M., Makova K., Nekrutenko A.,
RA   Elnitski L., Eswara P., King D.C., Yang S.-P., Tyekucheva S.,
RA   Radakrishnan A., Harris R.S., Chiaromonte F., Taylor J., He J.,
RA   Rijnkels M., Griffiths-Jones S., Ureta-Vidal A., Hoffman M.M., Severin J.,
RA   Searle S.M.J., Law A.S., Speed D., Waddington D., Cheng Z., Tuzun E.,
RA   Eichler E., Bao Z., Flicek P., Shteynberg D.D., Brent M.R., Bye J.M.,
RA   Huckle E.J., Chatterji S., Dewey C., Pachter L., Kouranov A.,
RA   Mourelatos Z., Hatzigeorgiou A.G., Paterson A.H., Ivarie R., Brandstrom M.,
RA   Axelsson E., Backstrom N., Berlin S., Webster M.T., Pourquie O.,
RA   Reymond A., Ucla C., Antonarakis S.E., Long M., Emerson J.J., Betran E.,
RA   Dupanloup I., Kaessmann H., Hinrichs A.S., Bejerano G., Furey T.S.,
RA   Harte R.A., Raney B., Siepel A., Kent W.J., Haussler D., Eyras E.,
RA   Castelo R., Abril J.F., Castellano S., Camara F., Parra G., Guigo R.,
RA   Bourque G., Tesler G., Pevzner P.A., Smit A., Fulton L.A., Mardis E.R.,
RA   Wilson R.K.;
RT   "Sequence and comparative analysis of the chicken genome provide unique
RT   perspectives on vertebrate evolution.";
RL   Nature 432:695-716(2004).
RN   [3] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INDUCTION, AND
RP   GLYCOSYLATION.
RX   PubMed=9472008;
RA   Romano P.R., Wang J., O'Keefe R.J., Puzas J.E., Rosier R.N., Reynolds P.R.;
RT   "HiPER1, a phosphatase of the endoplasmic reticulum with a role in
RT   chondrocyte maturation.";
RL   J. Cell Sci. 111:803-813(1998).
RN   [4] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, GLYCOSYLATION,
RP   AND MUTAGENESIS OF THR-27 AND GLN-78.
RX   PubMed=16759730; DOI=10.1016/j.jbiotec.2006.04.028;
RA   Cho J., Choi K., Darden T., Reynolds P.R., Petitte J.N., Shears S.B.;
RT   "Avian multiple inositol polyphosphate phosphatase is an active phytase
RT   that can be engineered to help ameliorate the planet's 'phosphate
RT   crisis'.";
RL   J. Biotechnol. 126:248-259(2006).
CC   -!- FUNCTION: Acts as a phosphoinositide 5- and phosphoinositide 6-
CC       phosphatase and regulates cellular levels of inositol pentakisphosphate
CC       (InsP5) and inositol hexakisphosphate (InsP6) (PubMed:9472008). Also
CC       acts as a 2,3-bisphosphoglycerate 3-phosphatase, by mediating the
CC       dephosphorylation of 2,3-bisphosphoglycerate (2,3-BPG) to produce
CC       phospho-D-glycerate without formation of 3-phosphoglycerate (By
CC       similarity). May play a role in bone development (endochondral
CC       ossification) (By similarity). May play a role in the transition of
CC       chondrocytes from proliferation to hypertrophy (PubMed:8660956,
CC       PubMed:9472008). {ECO:0000250|UniProtKB:Q9UNW1,
CC       ECO:0000269|PubMed:16759730, ECO:0000303|PubMed:8660956,
CC       ECO:0000303|PubMed:9472008}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Myo-inositol hexakisphosphate + H(2)O = myo-inositol
CC         pentakisphosphate (mixed isomers) + phosphate.; EC=3.1.3.62;
CC         Evidence={ECO:0000269|PubMed:16759730};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2R)-2,3-bisphosphoglycerate + H2O = (2R)-2-phosphoglycerate +
CC         phosphate; Xref=Rhea:RHEA:27381, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58248, ChEBI:CHEBI:58289; EC=3.1.3.80;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNW1};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=140 uM for inositol hexakisphosphate
CC         {ECO:0000269|PubMed:16759730};
CC         Vmax=715 nmol/min/mg enzyme with inositol hexakisphosphate as
CC         substrate {ECO:0000269|PubMed:16759730};
CC       pH dependence:
CC         Optimum pH is 4.5-7.5. {ECO:0000269|PubMed:16759730};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:9472008}.
CC   -!- TISSUE SPECIFICITY: Present in growth plate chondrocytes but not
CC       detectable in articular chondrocytes (at protein level)
CC       (PubMed:9472008). Spatially restricted to chondrocytes in the lower
CC       portion of the proliferative zone and the upper portion of the
CC       hypertrophic zone in the growth plate of long bones (at protein level)
CC       (PubMed:9472008). Weakly expressed in kidney, liver, lung, skin and
CC       spleen, and not detected in brain, heart and muscle (PubMed:8660956).
CC       {ECO:0000269|PubMed:8660956, ECO:0000269|PubMed:9472008}.
CC   -!- INDUCTION: Repressed by parathyroid hormone-related protein
CC       PTHLH/PTHRP. {ECO:0000269|PubMed:9472008}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:16759730,
CC       ECO:0000269|PubMed:9472008}.
CC   -!- MISCELLANEOUS: Monogastric animals cannot hydrolyze dietary inositol
CC       hexakisphosphate (InsP6) which makes up the bulk of organic phosphates
CC       in soybean, grains and other plant seeds which are the primary source
CC       of animal feed. The high activity of the chicken protein toward InsP6
CC       offers a genetic strategy for improving InsP6 digestion in poultry and
CC       reducing the pollution that results from high phosphate content in
CC       manure. {ECO:0000303|PubMed:16759730}.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family. MINPP1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U59421; AAB97100.1; -; mRNA.
DR   EMBL; AADN03005023; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_989975.1; NM_204644.1.
DR   STRING; 9031.ENSGALP00000005852; -.
DR   PaxDb; F1NPQ2; -.
DR   GeneID; 395356; -.
DR   KEGG; gga:395356; -.
DR   CTD; 9562; -.
DR   eggNOG; KOG1382; Eukaryota.
DR   HOGENOM; CLU_029165_3_1_1; -.
DR   OrthoDB; 1046588at2759; -.
DR   SABIO-RK; F1NPQ2; -.
DR   PRO; PR:F1NPQ2; -.
DR   Proteomes; UP000000539; Unplaced.
DR   Bgee; ENSGALG00000003695; Expressed in brain and 14 other tissues.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:UniProtKB.
DR   GO; GO:0003993; F:acid phosphatase activity; IBA:GO_Central.
DR   GO; GO:0034417; F:bisphosphoglycerate 3-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052826; F:inositol hexakisphosphate 2-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052745; F:inositol phosphate phosphatase activity; IBA:GO_Central.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   InterPro; IPR016274; Histidine_acid_Pase_euk.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   PIRSF; PIRSF000894; Acid_phosphatase; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Glycoprotein; Hydrolase; Reference proteome; Signal.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..448
FT                   /note="Multiple inositol polyphosphate phosphatase 1"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000437140"
FT   MOTIF           445..448
FT                   /note="Prevents secretion from ER"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10138"
FT   ACT_SITE        69
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2L6"
FT   CARBOHYD        203
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        257
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        409
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        441
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   MUTAGEN         27
FT                   /note="T->G: Loss of 96% of activity towards InsP6."
FT                   /evidence="ECO:0000269|PubMed:16759730"
FT   MUTAGEN         78
FT                   /note="Q->A: Two-fold greater substrate affinity and
FT                   doubling of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:16759730"
FT   CONFLICT        4
FT                   /note="R -> C (in Ref. 1; AAB97100)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        52
FT                   /note="S -> A (in Ref. 1; AAB97100)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        65..67
FT                   /note="AVL -> RVV (in Ref. 1; AAB97100)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        115
FT                   /note="D -> DG (in Ref. 1; AAB97100)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   448 AA;  50200 MW;  D62BA17068ECD5BA CRC64;
     MAPRRAACLL PLLVAVASAG LGGYFGTKSR YEEVNPHLAE DPLSLGPHAA ASRLPAACAP
     LQLRAVLRHG TRYPTAGQIR RLAELHGRLR RAAAPSCPAA AALAAWPMWY EESLDRLAPR
     GRRDMEHLAR RLAARFPALF AARRRLALAS SSKHRCLQSG AAFRRGLGPS LSLGADETEI
     EVNDALMRFF DHCDKFVAFV EDNDTAMYQV NAFKEGPEMR KVLEKVASAL CLPASELNAD
     LVQVAFLTCS YELAIKNVTS PWCSLFSEED AKVLEYLNDL KQYWKRGYGY DINSRSSCIL
     FQDIFQQLDK AVDESRSSKP ISSPLIVQVG HAETLQPLLA LMGYFKDAEP LQANNYIRQA
     HRKFRSGRIV PYAANLVFVL YHCEQKTSKE EYQVQMLLNE KPMLFHHSNE TISTYADLKS
     YYKDILQNCH FEEVCELPKV NGTVADEL
//
